Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression

Levi H C Makala, Babak Baban, Henrique Lemos, Ahmed R. El-Awady, Phillip R. Chandler, De Yan Hou, David H. Munn, Andrew L. Mellor

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Inflammation stimulates immunity but can create immune privilege in some settings. Here, we show that cutaneous Leishmania major infection stimulated expression of the immune regulatory enzyme indoleamine 2,3 dioxygenase (IDO) in local lymph nodes. Induced IDO attenuated the T cell stimulatory functions of dendritic cells and suppressed local T cell responses to exogenous and nominal parasite antigens. IDO ablation reduced local inflammation and parasite burdens, as did pharmacologic inhibition of IDO in mice with established infections. IDO ablation also enhanced local expression of proinflammatory cytokines and induced some CD4+ T cells to express interleukin (IL) 17. These findings showed that IDO induced by L. major infection attenuated innate and adaptive immune responses. Thus, IDO acts as a molecular switch regulating host responses, and IDO inhibitor drugs are a potential new approach to enhance host immunity to established leishmania infections.

Original languageEnglish (US)
Pages (from-to)715-725
Number of pages11
JournalJournal of Infectious Diseases
Volume203
Issue number5
DOIs
StatePublished - Mar 1 2011

Fingerprint

Indoleamine-Pyrrole 2,3,-Dioxygenase
Leishmania major
Immunity
Infection
T-Lymphocytes
Parasites
Inflammation
Interleukin-17
Leishmania
Adaptive Immunity
Innate Immunity
Dendritic Cells
Lymph Nodes
Cytokines
Antigens
Skin

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Makala, L. H. C., Baban, B., Lemos, H., El-Awady, A. R., Chandler, P. R., Hou, D. Y., ... Mellor, A. L. (2011). Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression. Journal of Infectious Diseases, 203(5), 715-725. https://doi.org/10.1093/infdis/jiq095

Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression. / Makala, Levi H C; Baban, Babak; Lemos, Henrique; El-Awady, Ahmed R.; Chandler, Phillip R.; Hou, De Yan; Munn, David H.; Mellor, Andrew L.

In: Journal of Infectious Diseases, Vol. 203, No. 5, 01.03.2011, p. 715-725.

Research output: Contribution to journalArticle

Makala, Levi H C ; Baban, Babak ; Lemos, Henrique ; El-Awady, Ahmed R. ; Chandler, Phillip R. ; Hou, De Yan ; Munn, David H. ; Mellor, Andrew L. / Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression. In: Journal of Infectious Diseases. 2011 ; Vol. 203, No. 5. pp. 715-725.
@article{f63b6e12f5fa4e3c9181a01fe71a9053,
title = "Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression",
abstract = "Inflammation stimulates immunity but can create immune privilege in some settings. Here, we show that cutaneous Leishmania major infection stimulated expression of the immune regulatory enzyme indoleamine 2,3 dioxygenase (IDO) in local lymph nodes. Induced IDO attenuated the T cell stimulatory functions of dendritic cells and suppressed local T cell responses to exogenous and nominal parasite antigens. IDO ablation reduced local inflammation and parasite burdens, as did pharmacologic inhibition of IDO in mice with established infections. IDO ablation also enhanced local expression of proinflammatory cytokines and induced some CD4+ T cells to express interleukin (IL) 17. These findings showed that IDO induced by L. major infection attenuated innate and adaptive immune responses. Thus, IDO acts as a molecular switch regulating host responses, and IDO inhibitor drugs are a potential new approach to enhance host immunity to established leishmania infections.",
author = "Makala, {Levi H C} and Babak Baban and Henrique Lemos and El-Awady, {Ahmed R.} and Chandler, {Phillip R.} and Hou, {De Yan} and Munn, {David H.} and Mellor, {Andrew L.}",
year = "2011",
month = "3",
day = "1",
doi = "10.1093/infdis/jiq095",
language = "English (US)",
volume = "203",
pages = "715--725",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression

AU - Makala, Levi H C

AU - Baban, Babak

AU - Lemos, Henrique

AU - El-Awady, Ahmed R.

AU - Chandler, Phillip R.

AU - Hou, De Yan

AU - Munn, David H.

AU - Mellor, Andrew L.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Inflammation stimulates immunity but can create immune privilege in some settings. Here, we show that cutaneous Leishmania major infection stimulated expression of the immune regulatory enzyme indoleamine 2,3 dioxygenase (IDO) in local lymph nodes. Induced IDO attenuated the T cell stimulatory functions of dendritic cells and suppressed local T cell responses to exogenous and nominal parasite antigens. IDO ablation reduced local inflammation and parasite burdens, as did pharmacologic inhibition of IDO in mice with established infections. IDO ablation also enhanced local expression of proinflammatory cytokines and induced some CD4+ T cells to express interleukin (IL) 17. These findings showed that IDO induced by L. major infection attenuated innate and adaptive immune responses. Thus, IDO acts as a molecular switch regulating host responses, and IDO inhibitor drugs are a potential new approach to enhance host immunity to established leishmania infections.

AB - Inflammation stimulates immunity but can create immune privilege in some settings. Here, we show that cutaneous Leishmania major infection stimulated expression of the immune regulatory enzyme indoleamine 2,3 dioxygenase (IDO) in local lymph nodes. Induced IDO attenuated the T cell stimulatory functions of dendritic cells and suppressed local T cell responses to exogenous and nominal parasite antigens. IDO ablation reduced local inflammation and parasite burdens, as did pharmacologic inhibition of IDO in mice with established infections. IDO ablation also enhanced local expression of proinflammatory cytokines and induced some CD4+ T cells to express interleukin (IL) 17. These findings showed that IDO induced by L. major infection attenuated innate and adaptive immune responses. Thus, IDO acts as a molecular switch regulating host responses, and IDO inhibitor drugs are a potential new approach to enhance host immunity to established leishmania infections.

UR - http://www.scopus.com/inward/record.url?scp=79751504300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79751504300&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiq095

DO - 10.1093/infdis/jiq095

M3 - Article

VL - 203

SP - 715

EP - 725

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 5

ER -